Surgery and Surgical Robotics
TransEnterix Bets on Haptics for Senhance Robot-Assisted Surgery Device
TransEnterix (NYSE:TRXC) is betting that the haptics technology in its Senhance robot-assisted surgery platform will help it make headway against Intuitive Surgical (NSDQ:ISRG) and its 10-year lead on the market. CEO Todd Pope told MassDevice.com that the Senhance’s haptics – the system’s...